MCL coexpression mm9:2223
From FANTOM5_SSTAR
Phase1 CAGE Peaks
Short description | |
---|---|
Mm9::chr17:71202091..71202110,+ | p@chr17:71202091..71202110 + |
Mm9::chr5:122286819..122286854,- | p1@Sh2b3 |
Mm9::chr7:26472013..26472031,+ | p1@Tgfb1 |
Mm9::chr7:26472296..26472360,+ | p2@Tgfb1 |
Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data
GO ID | GO name | FDR corrected p-value |
---|---|---|
GO:0030097 | hemopoiesis | 0.00745062589058729 |
GO:0048534 | hemopoietic or lymphoid organ development | 0.00745062589058729 |
GO:0002520 | immune system development | 0.00745062589058729 |
GO:0048298 | positive regulation of isotype switching to IgA isotypes | 0.00745062589058729 |
GO:0048296 | regulation of isotype switching to IgA isotypes | 0.00745062589058729 |
GO:0048290 | isotype switching to IgA isotypes | 0.00745062589058729 |
GO:0045066 | regulatory T cell differentiation | 0.00838172450320505 |
GO:0002513 | tolerance induction to self antigen | 0.00838172450320505 |
GO:0002507 | tolerance induction | 0.00993362356088819 |
GO:0035162 | embryonic hemopoiesis | 0.0111747141761175 |
GO:0005160 | transforming growth factor beta receptor binding | 0.0111747141761175 |
GO:0008354 | germ cell migration | 0.0111747141761175 |
GO:0045830 | positive regulation of isotype switching | 0.0117615679119517 |
GO:0042306 | regulation of protein import into nucleus | 0.0117615679119517 |
GO:0033157 | regulation of intracellular protein transport | 0.0117615679119517 |
GO:0030279 | negative regulation of ossification | 0.0117615679119517 |
GO:0032386 | regulation of intracellular transport | 0.0117615679119517 |
GO:0043029 | T cell homeostasis | 0.0117615679119517 |
GO:0051101 | regulation of DNA binding | 0.0117615679119517 |
GO:0051223 | regulation of protein transport | 0.0121036186066592 |
GO:0045191 | regulation of isotype switching | 0.0121036186066592 |
GO:0046822 | regulation of nucleocytoplasmic transport | 0.0121036186066592 |
GO:0016202 | regulation of striated muscle development | 0.0121036186066592 |
GO:0046851 | negative regulation of bone remodeling | 0.0121036186066592 |
GO:0042130 | negative regulation of T cell proliferation | 0.012124272964592 |
GO:0002376 | immune system process | 0.012124272964592 |
GO:0048535 | lymph node development | 0.0132830238819138 |
GO:0050868 | negative regulation of T cell activation | 0.0132830238819138 |
GO:0002260 | lymphocyte homeostasis | 0.0132830238819138 |
GO:0050672 | negative regulation of lymphocyte proliferation | 0.0132830238819138 |
GO:0032945 | negative regulation of mononuclear cell proliferation | 0.0132830238819138 |
GO:0051098 | regulation of binding | 0.0132830238819138 |
GO:0002208 | somatic diversification of immunoglobulins during immune response | 0.0132830238819138 |
GO:0002204 | somatic recombination of immunoglobulin genes during immune response | 0.0132830238819138 |
GO:0045190 | isotype switching | 0.0132830238819138 |
GO:0002381 | immunoglobulin production during immune response | 0.0132830238819138 |
GO:0030879 | mammary gland development | 0.0132830238819138 |
GO:0030278 | regulation of ossification | 0.0137813829400792 |
GO:0051250 | negative regulation of lymphocyte activation | 0.0137813829400792 |
GO:0001776 | leukocyte homeostasis | 0.0137813829400792 |
GO:0050871 | positive regulation of B cell activation | 0.0137813829400792 |
GO:0016447 | somatic recombination of immunoglobulin gene segments | 0.0137813829400792 |
GO:0048872 | homeostasis of number of cells | 0.0137813829400792 |
GO:0051241 | negative regulation of multicellular organismal process | 0.0137813829400792 |
GO:0046850 | regulation of bone remodeling | 0.0137813829400792 |
GO:0016444 | somatic cell DNA recombination | 0.0137813829400792 |
GO:0002562 | somatic diversification of immune receptors via germline recombination within a single locus | 0.0137813829400792 |
GO:0016445 | somatic diversification of immunoglobulins | 0.0139592077719214 |
GO:0002200 | somatic diversification of immune receptors | 0.0145851479348968 |
GO:0050864 | regulation of B cell activation | 0.0162005197383997 |
GO:0048568 | embryonic organ development | 0.0162005197383997 |
GO:0002377 | immunoglobulin production | 0.0167469160996042 |
GO:0002440 | production of molecular mediator of immune response | 0.0168517804801941 |
GO:0042129 | regulation of T cell proliferation | 0.0173657434817174 |
GO:0007179 | transforming growth factor beta receptor signaling pathway | 0.0186717639494633 |
GO:0048513 | organ development | 0.0191244399477819 |
GO:0050670 | regulation of lymphocyte proliferation | 0.0203964549816058 |
GO:0032944 | regulation of mononuclear cell proliferation | 0.0203964549816058 |
GO:0042098 | T cell proliferation | 0.0208062428871481 |
GO:0006606 | protein import into nucleus | 0.0208308910676066 |
GO:0051170 | nuclear import | 0.0208547110346113 |
GO:0051251 | positive regulation of lymphocyte activation | 0.0216073136941783 |
GO:0030217 | T cell differentiation | 0.0216073136941783 |
GO:0050863 | regulation of T cell activation | 0.0219658610872752 |
GO:0017038 | protein import | 0.0219706222464948 |
GO:0016064 | immunoglobulin mediated immune response | 0.0229274507513982 |
GO:0019724 | B cell mediated immunity | 0.0229274507513982 |
GO:0048731 | system development | 0.0229274507513982 |
GO:0032943 | mononuclear cell proliferation | 0.0229274507513982 |
GO:0006310 | DNA recombination | 0.0229274507513982 |
GO:0048732 | gland development | 0.0229274507513982 |
GO:0046651 | lymphocyte proliferation | 0.0229274507513982 |
GO:0048869 | cellular developmental process | 0.0232573811711488 |
GO:0030154 | cell differentiation | 0.0232573811711488 |
GO:0007178 | transmembrane receptor protein serine/threonine kinase signaling pathway | 0.0234943137786506 |
GO:0051249 | regulation of lymphocyte activation | 0.0237979600484555 |
GO:0051049 | regulation of transport | 0.0237979600484555 |
GO:0042113 | B cell activation | 0.0237979600484555 |
GO:0050865 | regulation of cell activation | 0.0237979600484555 |
GO:0002250 | adaptive immune response | 0.0237979600484555 |
GO:0002460 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 0.0237979600484555 |
GO:0030098 | lymphocyte differentiation | 0.0237979600484555 |
GO:0006913 | nucleocytoplasmic transport | 0.0237979600484555 |
GO:0002449 | lymphocyte mediated immunity | 0.0237979600484555 |
GO:0001503 | ossification | 0.0237979600484555 |
GO:0051169 | nuclear transport | 0.0237979600484555 |
GO:0016049 | cell growth | 0.0237979600484555 |
GO:0031214 | biomineral formation | 0.0237979600484555 |
GO:0007519 | skeletal muscle development | 0.0237979600484555 |
GO:0002443 | leukocyte mediated immunity | 0.0243809033882287 |
GO:0048856 | anatomical structure development | 0.0243809033882287 |
GO:0046849 | bone remodeling | 0.0249551449177405 |
GO:0008361 | regulation of cell size | 0.0256427030608344 |
GO:0042110 | T cell activation | 0.0276751578299701 |
GO:0008285 | negative regulation of cell proliferation | 0.0276751578299701 |
GO:0048771 | tissue remodeling | 0.0280202532627508 |
GO:0014706 | striated muscle development | 0.0280202532627508 |
GO:0007275 | multicellular organismal development | 0.028361058193276 |
GO:0002521 | leukocyte differentiation | 0.0285754315903206 |
GO:0002252 | immune effector process | 0.030065091026619 |
GO:0008083 | growth factor activity | 0.0328417615019168 |
GO:0007517 | muscle development | 0.0362131531844413 |
GO:0008284 | positive regulation of cell proliferation | 0.0380114415527461 |
GO:0016563 | transcription activator activity | 0.0380716457215351 |
GO:0001501 | skeletal development | 0.0381306564905467 |
GO:0006605 | protein targeting | 0.0392790963079813 |
GO:0046649 | lymphocyte activation | 0.0392790963079813 |
GO:0045321 | leukocyte activation | 0.0423958726799473 |
GO:0006954 | inflammatory response | 0.0424124169261955 |
GO:0032502 | developmental process | 0.0437515935107479 |
GO:0001775 | cell activation | 0.0442353946983323 |
GO:0045893 | positive regulation of transcription, DNA-dependent | 0.0467966770102563 |
GO:0007276 | gamete generation | 0.0491150881882739 |
Relative expression of the co-expression cluster over median <br>Analyst:
Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>
Ontology term | p-value | n |
---|---|---|
hematopoietic cell | 1.93e-16 | 32 |
hematopoietic oligopotent progenitor cell | 1.93e-16 | 32 |
hematopoietic stem cell | 1.93e-16 | 32 |
angioblastic mesenchymal cell | 1.93e-16 | 32 |
hematopoietic multipotent progenitor cell | 1.93e-16 | 32 |
connective tissue cell | 3.46e-15 | 46 |
mesenchymal cell | 3.46e-15 | 46 |
hematopoietic lineage restricted progenitor cell | 4.48e-14 | 25 |
common myeloid progenitor | 3.93e-11 | 19 |
motile cell | 1.75e-10 | 54 |
myeloid cell | 1.92e-09 | 16 |
leukocyte | 9.84e-09 | 17 |
nongranular leukocyte | 9.84e-09 | 17 |
nucleate cell | 4.17e-08 | 16 |
myeloid lineage restricted progenitor cell | 6.63e-08 | 13 |
lymphoid lineage restricted progenitor cell | 1.80e-07 | 12 |
T cell | 8.15e-07 | 11 |
pro-T cell | 8.15e-07 | 11 |
Ontology term | p-value | n |
---|---|---|
lateral plate mesoderm | 3.45e-16 | 87 |
hematopoietic system | 1.22e-15 | 45 |
blood island | 1.22e-15 | 45 |
hemolymphoid system | 1.88e-15 | 48 |
immune system | 1.88e-15 | 48 |
connective tissue | 3.46e-15 | 46 |
mesoderm | 1.92e-14 | 120 |
mesoderm-derived structure | 1.92e-14 | 120 |
presumptive mesoderm | 1.92e-14 | 120 |
bone marrow | 7.77e-10 | 16 |
musculoskeletal system | 2.64e-09 | 32 |
bone element | 4.31e-09 | 22 |
skeletal element | 4.31e-09 | 22 |
skeletal system | 4.31e-09 | 22 |
foregut | 1.38e-07 | 80 |
hemopoietic organ | 1.95e-07 | 29 |
immune organ | 1.95e-07 | 29 |
mixed endoderm/mesoderm-derived structure | 2.76e-07 | 35 |
TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data
Novel motifs
JASPAR motifs
Motifs | -log10(p-value) |
---|---|
MA0003.1 | 4.15047 |
MA0004.1 | 0.6888 |
MA0006.1 | 0.497533 |
MA0007.1 | 0.672186 |
MA0009.1 | 1.15569 |
MA0014.1 | 0.981995 |
MA0017.1 | 0.528196 |
MA0019.1 | 0.964875 |
MA0024.1 | 1.11019 |
MA0025.1 | 1.39562 |
MA0027.1 | 2.81824 |
MA0028.1 | 0.509589 |
MA0029.1 | 1.08753 |
MA0030.1 | 1.09438 |
MA0031.1 | 1.05719 |
MA0038.1 | 0.846479 |
MA0040.1 | 1.16866 |
MA0041.1 | 0.604221 |
MA0042.1 | 0.589368 |
MA0043.1 | 1.25564 |
MA0046.1 | 1.1929 |
MA0048.1 | 0.266382 |
MA0050.1 | 0.731539 |
MA0051.1 | 0.856094 |
MA0052.1 | 1.17701 |
MA0055.1 | 0.790894 |
MA0056.1 | 0 |
MA0057.1 | 1.29714 |
MA0058.1 | 0.581673 |
MA0059.1 | 0.59559 |
MA0060.1 | 0.403071 |
MA0061.1 | 2.91229 |
MA0063.1 | 0 |
MA0066.1 | 0.834648 |
MA0067.1 | 1.50873 |
MA0068.1 | 0.713436 |
MA0069.1 | 1.17737 |
MA0070.1 | 1.16732 |
MA0071.1 | 0.73062 |
MA0072.1 | 1.15853 |
MA0073.1 | 0.0140887 |
MA0074.1 | 0.795862 |
MA0076.1 | 0.550092 |
MA0077.1 | 1.13603 |
MA0078.1 | 0.891476 |
MA0081.1 | 1.5065 |
MA0083.1 | 1.25482 |
MA0084.1 | 1.84013 |
MA0087.1 | 1.21037 |
MA0088.1 | 0.582815 |
MA0089.1 | 0 |
MA0090.1 | 0.650768 |
MA0091.1 | 0.703314 |
MA0092.1 | 0.651119 |
MA0093.1 | 0.519148 |
MA0095.1 | 0 |
MA0098.1 | 0 |
MA0100.1 | 1.84237 |
MA0101.1 | 0.605676 |
MA0103.1 | 0.540576 |
MA0105.1 | 5.19185 |
MA0106.1 | 0.899777 |
MA0107.1 | 0.533522 |
MA0108.2 | 0.989014 |
MA0109.1 | 0 |
MA0111.1 | 0.666525 |
MA0113.1 | 0.869608 |
MA0114.1 | 0.43587 |
MA0115.1 | 1.25852 |
MA0116.1 | 1.24367 |
MA0117.1 | 1.22527 |
MA0119.1 | 0.606338 |
MA0122.1 | 1.24573 |
MA0124.1 | 1.45461 |
MA0125.1 | 1.37907 |
MA0130.1 | 0 |
MA0131.1 | 0.960068 |
MA0132.1 | 0 |
MA0133.1 | 0 |
MA0135.1 | 1.29308 |
MA0136.1 | 0.817395 |
MA0139.1 | 0.957842 |
MA0140.1 | 0.78318 |
MA0141.1 | 0.563066 |
MA0142.1 | 1.04199 |
MA0143.1 | 0.887119 |
MA0144.1 | 0.439506 |
MA0145.1 | 1.79187 |
MA0146.1 | 2.17792 |
MA0147.1 | 1.15069 |
MA0148.1 | 0.706718 |
MA0149.1 | 0.611881 |
MA0062.2 | 0.319836 |
MA0035.2 | 0.788288 |
MA0039.2 | 2.95164 |
MA0138.2 | 0.951653 |
MA0002.2 | 0.965577 |
MA0137.2 | 0.559766 |
MA0104.2 | 1.0034 |
MA0047.2 | 0.845655 |
MA0112.2 | 0.608441 |
MA0065.2 | 1.14711 |
MA0150.1 | 0.67206 |
MA0151.1 | 0 |
MA0152.1 | 0.84577 |
MA0153.1 | 1.31015 |
MA0154.1 | 0.728853 |
MA0155.1 | 2.6534 |
MA0156.1 | 0.549102 |
MA0157.1 | 1.0083 |
MA0158.1 | 0 |
MA0159.1 | 0.465802 |
MA0160.1 | 0.71003 |
MA0161.1 | 0 |
MA0162.1 | 2.99359 |
MA0163.1 | 1.64105 |
MA0164.1 | 0.817786 |
MA0080.2 | 0.534538 |
MA0018.2 | 0.828253 |
MA0099.2 | 0.944966 |
MA0079.2 | 10.3152 |
MA0102.2 | 1.8929 |
MA0258.1 | 0.419871 |
MA0259.1 | 0.441366 |
MA0442.1 | 0 |